Denali Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

MUN:4DN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
21 Aug 24	Sell€180,040	Alexander Schuth	Individual	8,353	€22.26
20 Aug 24	Sell€37,006	Steve Krognes	Individual	1,727	€21.43
20 Aug 24	Sell€48,426	Ryan Watts	Individual	2,260	€21.43
20 Aug 24	Sell€52,562	Carole Ho	Individual	2,453	€21.43
13 Aug 24	Sell€48,835	Carole Ho	Individual	2,337	€20.90
13 Aug 24	Sell€47,476	Alexander Schuth	Individual	2,272	€20.90
13 Jun 24	Sell€13,927	Steve Krognes	Individual	688	€20.24
13 Feb 24	Sell€43,809	Alexander Schuth	Individual	2,716	€16.13
13 Feb 24	Sell€44,905	Carole Ho	Individual	2,784	€16.13
13 Feb 24	Sell€154,669	Ryan Watts	Individual	9,589	€16.13
13 Feb 24	Sell€44,357	Steve Krognes	Individual	2,750	€16.13
10 Jan 24	Sell€80,999	Carole Ho	Individual	4,668	€17.35
09 Jan 24	Sell€141,527	Ryan Watts	Individual	7,818	€18.10
05 Jan 24	Sell€309,768	Ryan Watts	Individual	17,483	€17.72
05 Jan 24	Sell€176,686	Alexander Schuth	Individual	9,972	€17.72
05 Jan 24	Sell€56,840	Steve Krognes	Individual	3,208	€17.72
05 Jan 24	Sell€176,686	Carole Ho	Individual	9,972	€17.72

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 4DN?
Owner Type	Number of Shares	Ownership Percentage
General Public	428,551	0.298%
Individual Insiders	6,659,986	4.63%
Public Companies	7,155,243	4.97%
Institutions	129,677,844	90.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.1%.

Top Shareholders

Top 25 shareholders own 82.73% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.58%	BlackRock, Inc.	13,788,517	€325.8m	4.66%	0.01%
9.27%	Baillie Gifford & Co.	13,345,887	€315.3m	-3.03%	0.14%
7.77%	The Vanguard Group, Inc.	11,177,234	€264.1m	-1.2%	no data
7.45%	Wellington Management Group LLP	10,727,450	€253.4m	9.2%	0.04%
5.5%	Capital Research and Management Company	7,909,114	€186.9m	11%	0.01%
5.44%	FMR LLC	7,828,372	€184.9m	3,260%	0.01%
4.97%	Biogen Inc.	7,155,243	€169.0m	-43.9%	no data
3.72%	Temasek Holdings (Private) Limited	5,355,832	€126.5m	-6.14%	0.12%
3.1%	Crestline Investors Inc.	4,460,732	€105.4m	-6.3%	6.1%
2.95%	State Street Global Advisors, Inc.	4,252,011	€100.5m	-4.12%	no data
2.7%	UBS Asset Management AG	3,890,889	€91.9m	59.9%	0.01%
2.59%	Baker Bros. Advisors LP	3,731,695	€88.2m	0%	0.82%
2.12%	AllianceBernstein L.P.	3,047,264	€72.0m	51%	0.02%
2.05%	Geode Capital Management, LLC	2,955,477	€69.8m	-0.91%	0.01%
1.99%	T. Rowe Price Group, Inc.	2,869,795	€67.8m	27.2%	0.01%
1.56%	Ryan Watts	2,241,211	€52.9m	0%	no data
1.47%	Marc Tessier-Lavigne	2,111,441	€49.9m	0%	no data
1.39%	Camber Capital Management LP	2,000,000	€47.3m	0%	2.04%
1.37%	Marshall Wace LLP	1,967,141	€46.5m	-18.7%	0.07%
1.08%	Dimensional Fund Advisors LP	1,559,442	€36.8m	10%	0.01%
1.06%	Morgan Stanley, Investment Banking and Brokerage Investments	1,531,032	€36.2m	48.5%	no data
1.06%	Credit Suisse Asset Management (Switzerland) Ltd.	1,519,295	€35.9m	0%	0.04%
0.91%	BNY Asset Management	1,315,502	€31.1m	-13.8%	0.01%
0.86%	Principal Global Investors, LLC	1,238,499	€29.3m	13.8%	0.01%
0.76%	Artisan Partners Limited Partnership	1,091,018	€25.8m	-4.42%	0.02%